NYMC > News and Events > NYMC in the News

Lyme disease tests on the horizon

September 02, 2018

Lyme Disease Diagnostic CenterAnother group is aiming to detect Lyme disease with an immunoassay based on cytokines, small proteins that affect immune response to pathogens. Paul Arnaboldi, a professor at New York Medical College and lead research scientist at peptide synthesis company Biopeptides, is leading the project.

NYMC faculty: Paul M. Arnaboldi, Ph.D., assistant professor of microbiology and immunology

Source: Chemical and Engineering News